Cogent Biosciences (COGT) Enterprise Value (2017 - 2021)
Historic Enterprise Value for Cogent Biosciences (COGT) over the last 5 years, with Q3 2021 value amounting to -$202.9 million.
- Cogent Biosciences' Enterprise Value fell 5676.71% to -$202.9 million in Q3 2021 from the same period last year, while for Sep 2021 it was -$202.9 million, marking a year-over-year decrease of 5676.71%. This contributed to the annual value of -$242.2 million for FY2020, which is 54715.16% down from last year.
- Per Cogent Biosciences' latest filing, its Enterprise Value stood at -$202.9 million for Q3 2021, which was down 5676.71% from -$218.1 million recorded in Q2 2021.
- In the past 5 years, Cogent Biosciences' Enterprise Value registered a high of -$21.3 million during Q2 2020, and its lowest value of -$242.2 million during Q4 2020.
- In the last 5 years, Cogent Biosciences' Enterprise Value had a median value of -$82.5 million in 2018 and averaged -$107.1 million.
- As far as peak fluctuations go, Cogent Biosciences' Enterprise Value soared by 6187.75% in 2019, and later crashed by 92195.2% in 2021.
- Quarter analysis of 5 years shows Cogent Biosciences' Enterprise Value stood at -$49.6 million in 2017, then tumbled by 97.56% to -$97.9 million in 2018, then soared by 61.79% to -$37.4 million in 2019, then plummeted by 547.15% to -$242.2 million in 2020, then increased by 16.23% to -$202.9 million in 2021.
- Its Enterprise Value stands at -$202.9 million for Q3 2021, versus -$218.1 million for Q2 2021 and -$230.7 million for Q1 2021.